BD India Launches New Device to Minimize Patient Pain During Blood Collection Procedure

The device incorporates advanced technologies such as BD RightGauge and BD PentaPoint, enabling a gentler and safer blood collection experience.

Becton, Dickinson, and Company (BD) has introduced the BD Vacutainer UltraTouch Push Button Blood Collection Set in India to reduce patient pain and discomfort during blood collection procedures. 

The device incorporates advanced technologies such as BD RightGauge and BD PentaPoint, enabling a gentler and safer blood collection experience.

Commenting on the launch, Atul Grover, MD, BD India/South Asia, said, "Blood collection is often the first invasive procedure for patients, significantly impacting their overall experience. Our focus on enhancing healthcare extends to developing products like the BD Vacutainer UltraTouch, which promises improved patient satisfaction through reduced pain and increased success rates."

Grover highlighted the technological advancements incorporated into the BD Vacutainer UltraTouch, including the BD RightGauge and BD PentaPoint technologies. 

These innovations facilitate the use of thinner needles for blood collection, thereby minimizing insertion pain and increasing the likelihood of a successful blood draw. 

Additionally, the device features BD Push Button Technology, effectively reducing the risk of needle-related injuries by 88%. With its innovative technology, the device aims to reduce needle phobia associated with first-time blood collection, ensuring accurate test results and timely patient treatment.

Founded in 1897 by Maxwell Becton & Fairleigh DickinsonBD, BD is a global leader in MedTech focusing on improving medical discovery, diagnostics, and care delivery.

BD's Recent Initiatives

In light of a safety communication issued by the US Food and Drug Administration (FDA) concerning certain plastic syringes, BD recently bolstered domestic production to meet the heightened demand for syringes in the United States. 

Eric Borin, president, BD Medication Delivery Solutions, reassured customers of BD's focus on ensuring the uninterrupted provision of patient care.

"We have expanded our capacity to meet the increased demand for syringes and are further ramping up production in the United States to maintain continuity of patient care," Borin noted. 

Since the initial FDA safety communication in November 2023, BD has augmented domestic manufacturing of syringes at its facilities in Nebraska and Connecticut in response to customer requirements.

Advancements in Medical Devices Segment

In a significant development, Fujifilm India installed an Open MRI machine, "APERTO Lucent," at the Vijaya Diagnostic Center in Hyderabad. 

This advanced equipment is expected to enhance diagnostic accuracy and patient comfort, aligning with Fujifilm India's strategy to expand its presence in the Indian healthcare market.

Meanwhile, Hindustan Syringes and Medical Devices (HMD) has introduced Dispojekt single-use syringes with safety needles to address the pressing issue of needle stick injuries (NSIs) among healthcare workers. 

This launch signifies a significant step towards promoting workplace safety and reducing the financial burden of NSIs in the healthcare sector.

The adoption of safety needles in healthcare settings is applauded for its potential to mitigate the risks of needle stick injuries, thereby reducing healthcare worker injuries and associated costs.

With these advancements, the healthcare industry continues to witness innovations to enhance patient care and improve medical professionals' safety standards.